Patent details

EP2885288 Title: 1,4-DISUBSTITUTED PYRIDAZINE ANALOGS AND METHODS FOR TREATING SMN-DEFICIENCY-RELATED CONDITIONS

Basic Information

Publication number:
EP2885288
PCT Application Number:
US2013054687
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP137527685
PCT Publication Number:
WO2014028459
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
1,4-DISUBSTITUTED PYRIDAZINE ANALOGS AND METHODS FOR TREATING SMN-DEFICIENCY-RELATED CONDITIONS
French Title of Invention:
ANALOGUES DE PYRIDAZINE 1,4-DISUBSTITUÉE ET PROCÉDÉS DE TRAITEMENT D'ÉTATS ASSOCIÉS À UNE DÉFICIENCE DU SMN
German Title of Invention:
1,4-DISUBSTITUIERTE PYRIDAZIN-ANALOGA UND VERFAHREN ZUR BEHANDLUNG VON SMN-ASSOZIIERTEN ERKRANKUNGEN
SPC Number:

Dates

Filing date:
13/08/2013
Grant date:
06/10/2021
EP Publication Date:
24/06/2015
PCT Publication Date:
20/02/2014
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
06/10/2021
EP B1 Publication Date:
06/10/2021
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
13/08/2023
Expiration date:
13/08/2033
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
29/09/2021
 
 

Name:
Novartis AG
Address:
Lichtstrasse 35, 4056 Basel, Switzerland (CH)

Inventor

1

Name:
CHEUNG, Atwood
Address:
United States (US)

2

Name:
SHU, Lei
Address:
United States (US)

3

Name:
SUN, Robert
Address:
United States (US)

4

Name:
DALES, Natalie
Address:
United States (US)

5

Name:
SUNG, Moo
Address:
United States (US)

6

Name:
HURLEY, Timothy Brian
Address:
United States (US)

7

Name:
FAZAL, Aleem
Address:
United States (US)

8

Name:
KERRIGAN, John
Address:
United States (US)

9

Name:
CHIN, Donovan Noel
Address:
United States (US)

10

Name:
O'BRIEN, Gary
Address:
United States (US)

Priority

Priority Number:
201261682448 P
Priority Date:
13/08/2012
Priority Country:
United States (US)

Classification

IPC classification:
C07D 401/14; C07D 405/14; C07D 413/14; C07D 401/12; C07D 403/14; C07D 409/14; C07D 417/14; C07D 471/14; C07D 471/04; C07D 471/08; C07D 487/04; C07D 487/10; A61K 31/501; A61P 21/00;

Publication

European Patent Bulletin

1

Issue number:
202140
Publication date:
06/10/2021
Description:
Grant (B1)

2

Issue number:
202141
Publication date:
13/10/2021
Description:
Application number/publication number of the divisional application (Art. 76) changed

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
26/07/2022
Last Annual Fee Paid Number:
10
Last Annual Fee Paid Amount:
131 Euro
Payer:
CPA GLOBAL THE IP PLATFORM
Filing date Document type Number of pages